Antigen-specificity using chimeric antigen receptors: The future of regulatory T-cell therapy?

Biochemical Society Transactions

Volumn 44, Issue 2, 2016, Pages 342-348

  Boardman, Dominic ^a,b   Maher, John ^a   Lechler, Robert ^a,b   Smyth, Lesley ^a,c   Lombardi, Giovanna ^a,b  

^a GUY S HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

Adoptive cell therapy; Antigen specific; Autoimmune disease; Chimeric antigen receptor; Regulatory T cell; Transplantation

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR; ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CELL EXPANSION; CELL ISOLATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); EX VIVO STUDY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANTIGEN PRESENTING CELL; BIOLOGICAL THERAPY; IMMUNOLOGY;

ANTIGEN-PRESENTING CELLS; ANTIGENS; CELL- AND TISSUE-BASED THERAPY; HUMANS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 85009810373     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150247     Document Type: Article

References (50)

1. Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F. and Ochs, H.D. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21
2. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. and Yamaguchi, T. (2009) Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111
3. Gershon, R.K. and Kondo, K. (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737
4. Sakaguchi, S., Wing, K. and Miyara, M. (2007) Regulatory T cells - a brief history and perspective. Eur. J. Immunol. 37 Suppl 1, S116-S123
5. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164
6. Suri-Payer, E., Amar, A.Z., Thornton, A.M. and Shevach, E.M. (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212-1218
7. Kingsley, C.I., Karim, M., Bushell, A.R. and Wood, K.J. (2002) CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080-1086
8. Golshayan, D., Jiang, S., Tsang, J., Garin, M.I., Mottet, C. and Lechler, R.I. (2007) In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109, 827-835
9. Tsang, J.Y., Tanriver, Y., Jiang, S., Leung, E., Ratnasothy, K., Lombardi, G. and Lechler, R. (2009) Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression. Transpl. Immunol. 21, 203-209
10. Tsang, J.Y., Tanriver, Y., Jiang, S., Xue, S.A., Ratnasothy, K., Chen, D., Stauss, H.J., Bucy, R.P., Lombardi, G. and Lechler, R. (2008) Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 118, 3619-3628
11. Putnam, A.L., Safinia, N., Medvec, A., Laszkowska, M., Wray, M., Mintz, M.A., Trotta, E., Szot, G.L., Liu, W., Lares, A. et al. (2013) Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am. J. Transpl. 13, 3010-3020
12. Sagoo, P., Ali, N., Garg, G., Nestle, F.O., Lechler, R.I. and Lombardi, G. (2011) Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci. Transl. Med. 3, 83ra42
13. Louis, S., Braudeau, C., Giral, M., Dupont, A., Moizant, F., Robillard, N., Moreau, A., Soulillou, J.P. and Brouard, S. (2006) Contrasting CD25hiCD4+ T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 81, 398-407
14. Safinia, N., Leech, J., Hernandez-Fuentes, M., Lechler, R. and Lombardi, G. (2013) Promoting transplantation tolerance; adoptive regulatory T cell therapy. Clin. Exp. Immunol. 172, 158-168
15. Tang, Q., Henriksen, K.J., Bi, M., Finger, E.B., Szot, G., Ye, J., Masteller, E.L., McDevitt, H., Bonyhadi, M. and Bluestone, J.A. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465
16. Kohm, A.P., Carpentier, P.A., Anger, H.A. and Miller, S.D. (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716
17. Mottet, C., Uhlig, H.H. and Powrie, F. (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. 170, 3939-3943
18. Zheng, S.G., Wang, J.H., Koss, M.N., Quismorio, Jr, F., Gray, J.D. and Horwitz, D.A. (2004) CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 172, 1531-1539
19. Morgan, M.E., Flierman, R., van Duivenvoorde, L.M., Witteveen, H.J., van Ewijk, W., van Laar, J.M., de Vries, R.R. and Toes, R.E. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52, 2212-2221
20. Qureshi, O.S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E.M., Baker, J., Jeffery, L.E., Kaur, S., Briggs, Z. et al. (2011) Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332, 600-603
21. Smyth, L.A., Ratnasothy, K., Tsang, J.Y., Boardman, D., Warley, A., Lechler, R. and Lombardi, G. (2013) CD73 expression on extracellular vesicles derived from CD4 CD25 Foxp3 T cells contributes to their regulatory function. Eur. J. Immunol. 43, 2430-2440
22. Curotto de Lafaille, M.A. and Lafaille, J.J. (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30, 626-635
23. Safinia, N., Scotta, C., Vaikunthanathan, T., Lechler, R.I. and Lombardi, G. (2015) Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation. Front. Immunol. 6, 438
24. Desreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hebuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N. et al. (2012) Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143, 1207-1217.e1201-1202
25. O'Brien, J.D. and Ettinger, N.A. (1996) Pulmonary complications of liver transplantation. Clin. Chest Med. 17, 99-114
26. Taylor, P.A., Lees, C.J. and Blazar, B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499
27. Trzonkowski, P., Bacchetta, R., Battaglia, M., Berglund, D., Bohnenkamp, H.R., ten Brinke, A., Bushell, A., Cools, N., Geissler, E.K., Gregori, S. et al. (2015) Hurdles in therapy with regulatory T cells. Sci. Transl. Med. 7, 304ps318
28. Marek-Trzonkowska, N., Mysliwiec, M., Dobyszuk, A., Grabowska, M., Derkowska, I., Juscinska, J., Owczuk, m.R., Szadkowska, A., Witkowski, P., Mlynarski, W. et al. (2014) Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. Clin. Immunol. 153, 23-30
29. Bluestone, J.A., Buckner, J.H., Fitch, M., Gitelman, S.E., Gupta, S., Hellerstein, M.K., Herold, K.C., Lares, A., Lee, M.R., Li, K. et al. (2015) Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Sci. Transl. Med. 7, 315ra189
30. Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R.I., Cecchini, D. et al. (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117, 3921-3928
31. Brunstein, C.G., Miller, J.S., Cao, Q., McKenna, D.H., Hippen, K.L., Curtsinger, J., Defor, T., Levine, B.L., June, C.H., Rubinstein, P. et al. (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117, 1061-1070
32. Trzonkowski, P., Bieniaszewska, M., Juscinska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Mysliwska, J. and Hellmann, A. (2009) First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin. Immunol. 133, 22-26
33. Theil, A., Tuve, S., Oelschlagel, U., Maiwald, A., Dohler, D., Ossmann, D., Zenkel, A., Wilhelm, C., Middeke, J.M., Shayegi, N. et al. (2015) Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease. Cytotherapy 17, 473-486
34. Joffre, O., Santolaria, T., Calise, D., Al Saati, T., Hudrisier, D., Romagnoli, P. and van Meerwijk, J.P. (2008) Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14, 88-92
35. Cohen, C.J., Li, Y.F., El-Gamil, M., Robbins, P.F., Rosenberg, S.A. and Morgan, R.A. (2007) Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond. Cancer Res. 67, 3898-3903
36. Ochi, T., Fujiwara, H., Okamoto, S., An, J., Nagai, K., Shirakata, T., Mineno, J., Kuzushima, K., Shiku, H. and Yasukawa, M. (2011) Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood 118, 1495-1503
37. Berdien, B., Mock, U., Atanackovic, D. and Fehse, B. (2014) TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer. Gene Ther. 21, 539-548
38. Zhou, P., Borojevic, R., Streutker, C., Snider, D., Liang, H. and Croitoru, K. (2004) Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens. J. Immunol. 172, 1515-1523
39. Stephens, L.A., Malpass, K.H. and Anderton, S.M. (2009) Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 39, 1108-1117
40. DiPaolo, R.J., Brinster, C., Davidson, T.S., Andersson, J., Glass, D. and Shevach, E.M. (2007) Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179, 4685-4693
41. Fujio, K., Okamoto, A., Araki, Y., Shoda, H., Tahara, H., Tsuno, N.H., Takahashi, K., Kitamura, T. and Yamamoto, K. (2006) Gene therapy of arthritis with TCR isolated from the inflamed paw. J. Immunol. 177, 8140-8147
42. Wright, G.P., Notley, C.A., Xue, S.A., Bendle, G.M., Holler, A., Schumacher, T.N., Ehrenstein, M.R. and Stauss, H.J. (2009) Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proc. Natl. Acad. Sci. U.S.A. 106, 19078-19083
43. Tarbell, K.V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H., Suthanthiran, M., Mojsov, S. and Steinman, R.M. (2007) Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204, 191-201
44. Trenado, A., Sudres, M., Tang, Q., Maury, S., Charlotte, F., Gregoire, S., Bonyhadi, M., Klatzmann, D., Salomon, B.L. and Cohen, J.L. (2006) Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells. J. Immunol. 176, 1266-1273
45. Maher, J. (2012) Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells. ISRN Oncol. 2012, 278093
46. Gross, G., Waks, T. and Eshhar, Z. (1989) Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc. Natl. Acad. Sci. U.S.A. 86, 10024-10028
47. Blat, D., Zigmond, E., Alteber, Z., Waks, T. and Eshhar, Z. (2014) Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Mol. Ther. 22, 1018-1028
48. Elinav, E., Adam, N., Waks, T. and Eshhar, Z. (2009) Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor. Gastroenterology 136, 1721-1731
49. Elinav, E., Waks, T. and Eshhar, Z. (2008) Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Gastroenterology 134, 2014-2024
50. Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., Harris, R.A., Magnusson, P.U., Brittebo, E. and Loskog, A.S. (2012) CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. J. Neuroinflammation 9, 112